Navigation Links
AtheroNova Initiates Phase 1 Clinical Trial of AHRO-001, a Potential Treatment for Atherosclerosis
Date:6/25/2013

IRVINE, Calif., June 25, 2013 /PRNewswire/ -- AtheroNova Inc. (OTCBB: AHRO), a biotech company focused on the research and development of compounds to safely regress atherosclerotic plaque and improve lipid profiles in humans, today announces achievement of a major milestone with the initiation of a Phase 1 clinical trial with its lead compound, AHRO-001.  The Phase 1 study will evaluate the safety, tolerability and pharmacokinetics of AHRO-001 in healthy volunteers. The clinical study is being conducted in Russia with AtheroNova's licensing partner, OOO CardioNova.

"There is a significant unmet need for effective and well-tolerated agents in the treatment of both atherosclerosis and lipid modulation," said Thomas W. Gardner, Chairman and Chief Executive Officer of AtheroNova.  "Based on AHRO-001's preclinical profile, we believe it has the potential to offer patients effective treatment for these chronic conditions with an improved therapeutic profile.  We look forward to assessing AHRO-001 in human trials and are extremely pleased to have met a significant milestone with transitioning into a clinical stage company."

The Phase 1 study is a randomized, double-blind, placebo controlled study that assesses ascending doses of AHRO-001 in healthy adult volunteers.  The program advanced into Phase 1 clinical testing following extensive successful preclinical studies with AHRO-001.

"This is clearly an exciting and transformative time for us," remarked Mark K. Wedel, MD, Chief Medical Officer of AtheroNova.

About AHRO-001

AHRO-001 is AtheroNova's first novel application for the treatment and prevention of atherosclerosis. Atherosclerotic plaque is the primary, underlying cause of heart disease and stroke in industrialized countries. AtheroNova has shown positive results in animal models for regression of pl
'/>"/>

SOURCE AtheroNova Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. AtheroNova Announces Milestone Filing of IND in Russian Federation
2. AtheroNova Receives Notice of Allowance for Its US Patent Application 12/024,908
3. AtheroNova Signs Agreement for Development of Clinical Trial Supplies
4. Xenon Licenses Antisense Drug XEN701 From Isis and Initiates Preclinical Toxicology Studies
5. Spring Bank Pharmaceuticals Initiates a Phase I Clinical Trial for SB 9200 in HCV-infected Patients
6. AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy
7. Soligenix Initiates Phase 1 Clinical Study with SGX203 for the Treatment of Pediatric Crohns Disease
8. Ambrx Initiates Collaboration with Bristol-Myers Squibb for Discovery, Development of Next-Generation Antibody Drug Conjugates
9. Acutus Medical, Inc. Initiates "First-In-Man" Clinical Study of Real-Time 3D Imaging Catheter with CT/MRI Quality
10. ISIS Pharmaceuticals Initiates a Clinical Study of ISIS-SMN Rx in Infants With Spinal Muscular Atrophy
11. Romark Laboratories Initiates Phase 3 Trial of New Influenza Drug
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2015)... -- Ameritox,s Ingenuity Health, a leading provider of monitoring solutions ... the National Council of Behavioral Health annual conference in ... 25 percent of the samples collected from patients with ... antipsychotic medication. ... Medication nonadherence can ...
(Date:4/20/2015)... 2015 International Isotopes Inc. (OTCQB: INIS, ... with the following update on its business segments. ... Historically, INIS has produced and sold high-activity ... of sealed sources for medical and industrial applications.  ... security examination, and radiography.  Due to technical issues ...
(Date:4/20/2015)... NEW YORK , April 20, 2015 /PRNewswire/ ... insulin pump market will continue to be robust; ... increasing incidence of diabetes, expanding global markets, new ... growth, there are relatively steady market inhibitors, such ... and an increasing competitive environment. The healthcare market ...
Breaking Medicine Technology:Ingenuity Health Research Flags Potentially High Rate of Medication Nonadherence Among Those with Serious Mental Illness 2Ingenuity Health Research Flags Potentially High Rate of Medication Nonadherence Among Those with Serious Mental Illness 3International Isotopes Inc. Provides Shareholders With An Update On New Opportunities And Positive Developments Within Its Existing Business Segments 2International Isotopes Inc. Provides Shareholders With An Update On New Opportunities And Positive Developments Within Its Existing Business Segments 3International Isotopes Inc. Provides Shareholders With An Update On New Opportunities And Positive Developments Within Its Existing Business Segments 4International Isotopes Inc. Provides Shareholders With An Update On New Opportunities And Positive Developments Within Its Existing Business Segments 5Kalorama: Insulin Pump Market Growing Robustly 2Kalorama: Insulin Pump Market Growing Robustly 3
... HASCO Medical, Inc. (OTC Bulletin Board: HASC ... serves patients in Alabama, Florida, and Mississippi, today announced ... additional 8,000+ products available for immediate delivery. ... and affordable for patients throughout the United States to ...
... 25, 2011 Elekta,s MOSAIQ®* oncology electronic ... certification. Complete EMR certification officially validates the Elekta ... demonstrate Stage 1 meaningful use under the HITECH ... the Drummond Group,s Electronic Health Records Office of ...
Cached Medicine Technology:HASCO Medical Expands Online Offering 2Elekta's Oncology-Specific MOSAIQ Receives Complete ONC-ATCB EMR Certification 2Elekta's Oncology-Specific MOSAIQ Receives Complete ONC-ATCB EMR Certification 3
(Date:4/21/2015)... The University of Scranton has launched ... to answer the growing demand for professionals trained ... wellness profile for better individual, real-world care. , ... implementation of health services and systems. This is ... operations in the healthcare sector,” says Margarete Zalon, ...
(Date:4/21/2015)... (PRWEB) April 21, 2015 On ... the grand opening of its Center for Graduate ... Hollywood Presbyterian Hospital. The campus recently completed a ... the only thing that has administrators and students ... expanded from the Master of Science in Nursing, ...
(Date:4/21/2015)... Springs, FL (PRWEB) April 21, 2015 ... these are a few of the Earth Day topics ... As state and national leaders debate the affect of ... offers a variety of subject matter touching on the ... The compelling segments will delve into sustainable lifestyles, clean ...
(Date:4/21/2015)... This program provides physical therapists, ... occupational therapist assistants, teachers, and other school based ... children across the autism spectrum succeed in the ... Inc. , Used throughout the United ... yoga curriculum addresses learning and behavior issues across ...
(Date:4/20/2015)... Falls Church, VA (PRWEB) April 21, 2015 ... How Sponsors and CMOs Speed Production and Improve Compliance ... – 3:00 p.m. EDT, http://www.fdanews.com/qualitybydesign , The ... that are forcing them to do more with less. ... forcing sponsors and CMOs to finds ways to speed ...
Breaking Medicine News(10 mins):Health News:The University of Scranton Launches Online MS in Health Informatics 2Health News:The University of Scranton Launches Online MS in Health Informatics 3Health News:West Coast University Opens a Center for Graduate Studies 2Health News:West Coast University Opens a Center for Graduate Studies 3Health News:USM Studios’ Programming Focuses on the Environment 2Health News:ABC News Interviews Anne Buckley-Reen, Education Resources Inc. Faculty Member, on Yoga Therapy in the Classroom 2Health News:FDAnews Announces — Using Quality by Design to Improve Manufacturing: How Sponsors and CMOs Speed Production and Improve Compliance Webinar, May 7, 2015 2Health News:FDAnews Announces — Using Quality by Design to Improve Manufacturing: How Sponsors and CMOs Speed Production and Improve Compliance Webinar, May 7, 2015 3
... RBC Life Sciences (OTC Bulletin Board: RBCL) announced ... Price, to CEO effective January 1, 2009. Company founder, ... chairman of the board of directors.The promotion comes at ... of proprietary nutritional supplements, wound care and pain management ...
... Dental Network of America (DNoA) and Philips Consumer ... America Corporation (Philips), just signed an agreement, effective ... "DNoA Preferred Network" dentists in Illinois, Oklahoma and ... Sonicare(TM) product line."Partnering with Philips on offering the ...
... January 30th noon to 5PM in our new Hyundai Dealer showroom at 271 ... the first 50 to donate blood. , ... Wilmington, MA (PRWEB) January 5, 2009 -- Bill Dube ... blood as the recent ice & snow storms that hit New England have canceled ...
... China, Jan. 5 /PRNewswire-Asia-FirstCall/ -- China Nepstar Chain,Drugstore ... "the Company"), the largest retail,drugstore chain in China ... announced that its Board of Directors and the ... termination of a voting rights agreement which,assigned 30% ...
... foods consumed during pregnancy might protect against asthma and ... apple a day while you,re pregnant may indeed keep ... your unborn child. , Recent research suggests ... have lower rates of asthma. , And, mothers who ...
... Today,s fast-paced,demanding culture often makes it challenging to ... health. Karate, which is most commonly,recognized as a means ... to help anyone achieve a fit body; relieve stress; ... her leadership skills. , Karate ...
Cached Medicine News:Health News:RBC Life Sciences Promotes Industry Veteran John W. Price to CEO; Company Founder, Clinton Howard, Will Remain Chairman of the Board 2Health News:RBC Life Sciences Promotes Industry Veteran John W. Price to CEO; Company Founder, Clinton Howard, Will Remain Chairman of the Board 3Health News:Dental Network of America and Philips Sign Agreement to Offer Sonicare Products to Dental Providers 2Health News:Boston Hyundai Dealer Teams up With the Red Cross to Save Lives 2Health News:China Nepstar Chain Drugstore Terminates Voting Rights Agreement for Yunnan Subsidiary 2Health News:China Nepstar Chain Drugstore Terminates Voting Rights Agreement for Yunnan Subsidiary 3Health News:China Nepstar Chain Drugstore Terminates Voting Rights Agreement for Yunnan Subsidiary 4Health News:Prenatal Nutrition, Postnatal Allergy Protection 2Health News:Prenatal Nutrition, Postnatal Allergy Protection 3Health News:Karate For Your Body Announces Release of Volume One in Martial Arts DVD Training Series, 'Focusing On Fundamentals' 2
... The Bledsoe Wee Walker Pediatric ... low profile pediatric boot that ... unsurpassed support. Only two sizes ... cost. These sizes will fit ...
... is a shorter and lighter version ... second degree ankle sprains, toe and ... Bledsoe EZ Set Mid-Calf Boot is ... 20 degrees of dorsi-flexion to 40 ...
... Diabetic Boot features a fully enclosed thick, ... unique auto-molding innersole which embeds into a ... aluminum shelled walking boot. This unique Automold™ ... distribute body weight across the entire bottom ...
... Bird and Cronin, ... manufacturer of Patient Footwear, ... Patient Care Products. Our ... highest quality and available ...
Medicine Products: